436 related articles for article (PubMed ID: 26221598)
1. MicroRNA-143/-145 in Cardiovascular Diseases.
Zhao W; Zhao SP; Zhao YH
Biomed Res Int; 2015; 2015():531740. PubMed ID: 26221598
[TBL] [Abstract][Full Text] [Related]
2. miRNAs as potential therapeutic targets and diagnostic biomarkers for cardiovascular disease with a particular focus on WO2010091204.
Yang Y; Yu T; Jiang S; Zhang Y; Li M; Tang N; Ponnusamy M; Wang JX; Li PF
Expert Opin Ther Pat; 2017 Sep; 27(9):1021-1029. PubMed ID: 28627982
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-31 controls phenotypic modulation of human vascular smooth muscle cells by regulating its target gene cellular repressor of E1A-stimulated genes.
Wang J; Yan CH; Li Y; Xu K; Tian XX; Peng CF; Tao J; Sun MY; Han YL
Exp Cell Res; 2013 May; 319(8):1165-75. PubMed ID: 23518389
[TBL] [Abstract][Full Text] [Related]
4. Roles of miR-17-92 Cluster in Cardiovascular Development and Common Diseases.
Gu H; Liu Z; Zhou L
Biomed Res Int; 2017; 2017():9102909. PubMed ID: 28164128
[TBL] [Abstract][Full Text] [Related]
5. The role of miR-214 in cardiovascular diseases.
Zhao Y; Ponnusamy M; Zhang L; Zhang Y; Liu C; Yu W; Wang K; Li P
Eur J Pharmacol; 2017 Dec; 816():138-145. PubMed ID: 28842125
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA208 family in cardiovascular diseases: therapeutic implication and potential biomarker.
Huang Y; Li J
J Physiol Biochem; 2015 Sep; 71(3):479-86. PubMed ID: 25840809
[TBL] [Abstract][Full Text] [Related]
8. Role of microRNAs in stem/progenitor cells and cardiovascular repair.
Jakob P; Landmesser U
Cardiovasc Res; 2012 Mar; 93(4):614-22. PubMed ID: 22135162
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs as Candidate Drug Targets for Cardiovascular Diseases.
Hang P; Guo J; Sun C; Du Z
Curr Drug Targets; 2017; 18(4):463-472. PubMed ID: 26926467
[TBL] [Abstract][Full Text] [Related]
10. miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges.
Zhou SS; Jin JP; Wang JQ; Zhang ZG; Freedman JH; Zheng Y; Cai L
Acta Pharmacol Sin; 2018 Jul; 39(7):1073-1084. PubMed ID: 29877320
[TBL] [Abstract][Full Text] [Related]
11. Extracellular vesicle microRNA transfer in cardiovascular disease.
Das S; Halushka MK
Cardiovasc Pathol; 2015; 24(4):199-206. PubMed ID: 25958013
[TBL] [Abstract][Full Text] [Related]
12. microRNAs in cardiovascular diseases: current knowledge and the road ahead.
Condorelli G; Latronico MV; Cavarretta E
J Am Coll Cardiol; 2014 Jun; 63(21):2177-87. PubMed ID: 24583309
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-based therapeutic approaches in the cardiovascular system.
Fiedler J; Gupta SK; Thum T
Cardiovasc Ther; 2012 Feb; 30(1):e9-e15. PubMed ID: 20946325
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular importance of the microRNA-23/27/24 family.
Bang C; Fiedler J; Thum T
Microcirculation; 2012 Apr; 19(3):208-14. PubMed ID: 22136461
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA Signature and Cardiovascular Dysfunction.
Arunachalam G; Upadhyay R; Ding H; Triggle CR
J Cardiovasc Pharmacol; 2015 May; 65(5):419-29. PubMed ID: 25384197
[TBL] [Abstract][Full Text] [Related]
16. The Emerging Role of MicroRNA-155 in Cardiovascular Diseases.
Cao RY; Li Q; Miao Y; Zhang Y; Yuan W; Fan L; Liu G; Mi Q; Yang J
Biomed Res Int; 2016; 2016():9869208. PubMed ID: 28018919
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs: a novel class of potential therapeutic targets for cardiovascular diseases.
Pan ZW; Lu YJ; Yang BF
Acta Pharmacol Sin; 2010 Jan; 31(1):1-9. PubMed ID: 19966833
[TBL] [Abstract][Full Text] [Related]
18. The Role of microRNA in the Development, Diagnosis, and Treatment of Cardiovascular Disease: Recent Developments.
Wronska A
J Pharmacol Exp Ther; 2023 Jan; 384(1):123-132. PubMed ID: 35779862
[TBL] [Abstract][Full Text] [Related]
19. [Epigenetic factors in atherogenesis: microRNA].
Smirnova AV; Sukhorukov VN; Karagodin VP; Orekhov AN
Biomed Khim; 2016; 62(2):134-40. PubMed ID: 27143369
[TBL] [Abstract][Full Text] [Related]
20. MiR-133a modulates osteogenic differentiation of vascular smooth muscle cells.
Liao XB; Zhang ZY; Yuan K; Liu Y; Feng X; Cui RR; Hu YR; Yuan ZS; Gu L; Li SJ; Mao DA; Lu Q; Zhou XM; de Jesus Perez VA; Yuan LQ
Endocrinology; 2013 Sep; 154(9):3344-52. PubMed ID: 23798596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
